ArticleOncotarget2017

PI3K isoform inhibition associated with anti Bcr-Abl drugs shows in vitro increased anti-leukemic activity in Philadelphia chromosome-positive B-acute lymphoblastic leukemia cell lines.

Simona Ultimo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.